AstraZeneca Faslodex Is First Launch For Doubled Oncology Sales Force

29 Apr 2002

• By The Pink Sheet

AstraZeneca's Faslodex is the first launch to be detailed by the company's recently-expanded oncology sales force, following FDA approval of the estrogen receptor down-regulator April 25

AstraZeneca Faslodex Is First Launch For Doubled Oncology Sales Force

More from Archive

More from Pink Sheet